Filter Results :

Your search for Lymphoma returned 126 reports

Sort by


Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Burkitt Lymphoma-API Insights, 2015,report provides Burkitt Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this B-Cell Non-Hodgkin Lymphoma. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under ...

$ 1,250.00

Read More

Acute Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Acute Lymphoblastic Lymphoma-API Insights, 2015,report provides Acute Lymphoblastic Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe ...

$ 1,250.00

Read More

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Peripheral T-Cell Lymphomas (PTCL)-API Insights, 2015,report provides Peripheral T-Cell Lymphomas (PTCL) drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF)...

$ 1,250.00

Read More

Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Hodgkin Lymphoma-API Insights, 2015,report provides Hodgkin Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More

Lymphoblastic Lymphoma-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Lymphoblastic Lymphoma-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Lymphoblastic Lymphoma. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under Lymphoblas...

$ 1,250.00

Read More

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Cutaneous T-Cell Lymphoma-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Cutaneous T-Cell Lymphoma. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under Cuta...

$ 1,250.00

Read More

Indolent Lymphoma-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Indolent Lymphoma-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Indolent Lymphoma. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under Indolent Lymphoma. T...

$ 1,250.00

Read More

Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Follicular Lymphoma-API Insights, 2015,report provides Follicular Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by world...

$ 1,250.00

Read More

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Cutaneous T-Cell Lymphoma-API Insights, 2015,report provides Cutaneous T-Cell Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF fi...

$ 1,250.00

Read More

B-Cell Lymphomas-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ B-Cell Lymphomas-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this B-Cell Lymphomas. A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs that fall under B-Cell Lymphomas. The ...

$ 1,250.00

Read More

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, T-Cell Lymphomas-API Insights, 2015,report provides T-Cell Lymphomas drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More

Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Mantle Cell Lymphoma-API Insights, 2015,report provides Mantle Cell Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by wor...

$ 1,250.00

Read More

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
SUMMARYDelveInsight’s, “ Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this Peripheral T-Cell Lymphomas (PTCL). A key objective of DelveInsight’s report is to establish the understanding for all the pipeline drugs tha...

$ 1,250.00

Read More

Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Lymphoblastic Lymphoma-API Insights, 2015,report provides Lymphoblastic Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by...

$ 1,250.00

Read More
Total 126 records.